29 Aug 2019
Chr. Hansen and Lonza’s newly branded joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of live biotherapeutic products
Copenhagen, Denmark and Basel, Switzerland, 29 August 2019 – Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading...